IGN — Inno-Gene SA Income Statement
0.000.00%
Last trade - 00:00
- PLN10.38m
- PLN5.73m
- PLN1.13m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | PRESS | PRESS |
Standards: | PAS | PAS | PAS | — | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.36 | 4.68 | 29.9 | 16.3 | 1.13 |
Cost of Revenue | |||||
Gross Profit | 1.23 | 3.25 | 22.4 | 12 | 0.443 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1.61 | 3.2 | 21.2 | 16.3 | 3.43 |
Operating Profit | -0.255 | 1.48 | 8.66 | -0.041 | -2.3 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.272 | 1.66 | 8.52 | 0.786 | -1.19 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.285 | 1.45 | 6.14 | 0.33 | -1.46 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.165 | 1.57 | 6.14 | 0.33 | -1.46 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.165 | 1.57 | 6.14 | 0.33 | -1.46 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.035 | 0.276 | 1.08 | 0.058 | -0.256 |
Dividends per Share |